Revvity, Inc. (RVTY)
 NYSE: RVTY · Real-Time Price · USD
 92.63
 +1.61 (1.77%)
  Oct 31, 2025, 11:10 AM EDT - Market open
Revvity Revenue
Revvity had revenue of $698.95M in the quarter ending September 28, 2025, with 2.18% growth. This brings the company's revenue in the last twelve months to $2.81B, up 3.37% year-over-year. In the year 2024, Revvity had annual revenue of $2.76B with 0.16% growth.
Revenue (ttm) 
 $2.81B
Revenue Growth 
 +3.37%
P/S Ratio 
 3.84
Revenue / Employee 
 $255,761
Employees 
 11,000
Market Cap 
10.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% | 
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% | 
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% | 
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% | 
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% | 
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| AbbVie | 59.64B | 
| Eli Lilly and Company | 59.42B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
RVTY News
- 3 days ago - Revvity Analysts Increase Their Forecasts After Q3 Earnings - Benzinga
- 3 days ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 3 days ago - Revvity: Software Momentum And Screening Offset China Weakness - Seeking Alpha
- 3 days ago - Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Revvity lifts annual profit forecast on renewed demand in diagnostics unit - Reuters
- 4 days ago - Revvity Announces Financial Results for the Third Quarter of 2025 - Business Wire
- 7 days ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 17 days ago - Revvity Showcases Progress with Purpose in 2025 Impact Report - Business Wire